Skip to content
Home/Companies/Biotech/Biotechnology Development for Industry in Pharmaceuticals

Biotechnology Development for Industry in Pharmaceuticals

Biotech·Spain·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Biotechnology Development for Industry in Pharmaceuticals?

Biotechnology Development for Industry in Pharmaceuticals is currently owned by Sodical through ADE Capital Sodical (1991 vintage), since 2021.

Hand-verified · updated 2026-08-03

Sodical
Investor
Sodical
ADE Capital Sodical · 1991 · Growth

Key facts

HQSpain
SectorBiotech
StatusActive

More from ADE Capital Sodical

Other portfolio companies in the same fund.

Celldrive 3D
Active
BiotechSpain· 2025
Moralejo Seleccion
Active
ConsumerSpain· 2025
Uniqoders Technologies
Uniqoders Technologies
Active
SoftwareSpain· 2025
300K Solutions
300K Solutions
Active
BiotechSpain· 2024
Agropecuaria La Serrota
Active
AgricultureSpain· 2024
Articae Smart Technologies
Articae Smart Technologies
Active
SoftwareSpain· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Biotechnology Development for Industry in Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Biotechnology Development for Industry in Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue